Antibody Drug Conjugates Market Size, Share & Trends Report

Antibody Drug Conjugates Market (2025 - 2033) Size, Share & Trends Analysis Report By Application (Blood Cancer, Urothelial Carcinoma, Ovarian Cancer, Breast Cancer, Other Cancer), By Product, By Payload, By Technology, By Distribution Channel, By Region, And Segment Forecasts

Market Segmentation

Antibody Drug Conjugates Application Outlook (Revenue, USD Million, 2021 - 2033)
- Breast Cancer
- Blood Cancer
  - Lymphoma
  - Leukemia
- Urothelial Carcinoma
- Ovarian Cancer
- Others
Antibody Drug Conjugates Product Outlook (Revenue, USD Million, 2021 - 2033)
- Kadcyla
- Enhertu
- Trodelvy
- Adcetris
- Polivy
- Others
Antibody Drug Conjugates Payload Outlook (Revenue, USD Million, 2021 - 2033)
- Auristatins (MMAE, MMAF)
- Maytansinoids (DM1, DM4)
- Calicheamicin Derivatives
- Topoisomerase I Inhibitors (SN-38, DXd)
- Pyrrolobenzodiazepine (PBD) Dimers
- Others
Antibody Drug Conjugates Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Cleavable Linker
- Non-Cleavable Linker
- Others
Antibody Drug Conjugates Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Hospital Pharmacy
- Specialty Pharmacy
- Others
Antibody Drug Conjugates Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - North America Antibody Drug Conjugates Market, by Application
    - Breast Cancer
    - Blood Cancer
      - Lymphoma
      - Leukemia
    - Urothelial Carcinoma
    - Ovarian Cancer
    - Others
  - North America Antibody Drug Conjugates Market, by Product
    - Kadcyla (ado-trastuzumab emtansine)
    - Enhertu (trastuzumab deruxtecan)
    - Trodelvy (sacituzumab govitecan)
    - Adcetris (brentuximab vedotin)
    - Polivy (polatuzumab vedotin)
    - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
  - North America Antibody Drug Conjugates Market, by Payload
    - Auristatins
    - Maytansinoids
    - Calicheamicin Derivatives
    - Others
  - North America Antibody Drug Conjugates Market, by Technology
    - Auristatins (MMAE, MMAF)
    - Maytansinoids (DM1, DM4)
    - Calicheamicin Derivatives
    - Topoisomerase I Inhibitors (SN-38, DXd)
    - Pyrrolobenzodiazepine (PBD) Dimers
    - Others
  - North America Antibody Drug Conjugates Market, by Distribution Channel
    - Hospital Pharmacy
    - Specialty Pharmacy
    - Others
  - U.S.
    - U.S. Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - U.S. Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - U.S. Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - U.S. Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - U.S. Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Canada
    - Canada Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Canada Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Canada Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Canada Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Canada Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Mexico
    - Mexico Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Mexico Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Mexico Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Mexico Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Mexico Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
- Europe
  - Europe Antibody Drug Conjugates Market, by Application
    - Breast Cancer
    - Blood Cancer
      - Lymphoma
      - Leukemia
    - Urothelial Carcinoma
    - Ovarian Cancer
    - Others
  - Europe Antibody Drug Conjugates Market, by Product
    - Kadcyla (ado-trastuzumab emtansine)
    - Enhertu (trastuzumab deruxtecan)
    - Trodelvy (sacituzumab govitecan)
    - Adcetris (brentuximab vedotin)
    - Polivy (polatuzumab vedotin)
    - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
  - Europe Antibody Drug Conjugates Market, by Payload
    - Auristatins
    - Maytansinoids
    - Calicheamicin Derivatives
    - Others
  - Europe Antibody Drug Conjugates Market, by Technology
    - Auristatins (MMAE, MMAF)
    - Maytansinoids (DM1, DM4)
    - Calicheamicin Derivatives
    - Topoisomerase I Inhibitors (SN-38, DXd)
    - Pyrrolobenzodiazepine (PBD) Dimers
    - Others
  - Europe Antibody Drug Conjugates Market, by Distribution Channel
    - Hospital Pharmacy
    - Specialty Pharmacy
    - Others
  - UK
    - UK Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - UK Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - UK Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - UK Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - UK Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Germany
    - Germany Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Germany Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Germany Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Germany Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Germany Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - France
    - France Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - France Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - France Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - France Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - France Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Italy
    - Italy Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Italy Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Italy Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Italy Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Italy Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Spain
    - Spain Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Spain Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Spain Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Spain Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Spain Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Denmark
    - Denmark Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Denmark Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Denmark Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Denmark Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Denmark Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Sweden
    - Sweden Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Sweden Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Sweden Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Sweden Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Sweden Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Norway
    - Norway Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Norway Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Norway Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Norway Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Norway Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
- Asia Pacific
  - Asia Pacific Antibody Drug Conjugates Market, by Application
    - Breast Cancer
    - Blood Cancer
      - Lymphoma
      - Leukemia
    - Urothelial Carcinoma
    - Ovarian Cancer
    - Others
  - Asia Pacific Antibody Drug Conjugates Market, by Product
    - Kadcyla (ado-trastuzumab emtansine)
    - Enhertu (trastuzumab deruxtecan)
    - Trodelvy (sacituzumab govitecan)
    - Adcetris (brentuximab vedotin)
    - Polivy (polatuzumab vedotin)
    - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
  - Asia Pacific Antibody Drug Conjugates Market, by Payload
    - Auristatins
    - Maytansinoids
    - Calicheamicin Derivatives
    - Others
  - Asia Pacific Antibody Drug Conjugates Market, by Technology
    - Auristatins (MMAE, MMAF)
    - Maytansinoids (DM1, DM4)
    - Calicheamicin Derivatives
    - Topoisomerase I Inhibitors (SN-38, DXd)
    - Pyrrolobenzodiazepine (PBD) Dimers
    - Others
  - Asia Pacific Antibody Drug Conjugates Market, by Distribution Channel
    - Hospital Pharmacy
    - Specialty Pharmacy
    - Others
  - Japan
    - Japan Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Japan Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Japan Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Japan Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Japan Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - China
    - China Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - China Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - China Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - China Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - China Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - India
    - India Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - India Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - India Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - India Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - India Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Australia
    - Australia Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Australia Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Australia Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Australia Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Australia Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - South Korea
    - South Korea Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - South Korea Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - South Korea Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - South Korea Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - South Korea Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Thailand
    - Thailand Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Thailand Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Thailand Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Thailand Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Thailand Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
- Latin America
  - Latin America Antibody Drug Conjugates Market, by Application
    - Breast Cancer
    - Blood Cancer
      - Lymphoma
      - Leukemia
    - Urothelial Carcinoma
    - Ovarian Cancer
    - Others
  - Latin America Antibody Drug Conjugates Market, by Product
    - Kadcyla (ado-trastuzumab emtansine)
    - Enhertu (trastuzumab deruxtecan)
    - Trodelvy (sacituzumab govitecan)
    - Adcetris (brentuximab vedotin)
    - Polivy (polatuzumab vedotin)
    - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
  - Latin America Antibody Drug Conjugates Market, by Payload
    - Auristatins
    - Maytansinoids
    - Calicheamicin Derivatives
    - Others
  - Latin America Antibody Drug Conjugates Market, by Technology
    - Auristatins (MMAE, MMAF)
    - Maytansinoids (DM1, DM4)
    - Calicheamicin Derivatives
    - Topoisomerase I Inhibitors (SN-38, DXd)
    - Pyrrolobenzodiazepine (PBD) Dimers
    - Others
  - Latin America Antibody Drug Conjugates Market, by Distribution Channel
    - Hospital Pharmacy
    - Specialty Pharmacy
    - Others
  - Brazil
    - Brazil Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Brazil Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Brazil Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Brazil Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Brazil Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Argentina
    - Argentina Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Argentina Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Argentina Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Argentina Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Argentina Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
- Middle East & Africa
  - Middle East & Africa Antibody Drug Conjugates Market, by Application
    - Breast Cancer
    - Blood Cancer
      - Lymphoma
      - Leukemia
    - Urothelial Carcinoma
    - Ovarian Cancer
    - Others
  - Middle East & Africa Antibody Drug Conjugates Market, by Product
    - Kadcyla (ado-trastuzumab emtansine)
    - Enhertu (trastuzumab deruxtecan)
    - Trodelvy (sacituzumab govitecan)
    - Adcetris (brentuximab vedotin)
    - Polivy (polatuzumab vedotin)
    - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
  - Middle East & Africa Antibody Drug Conjugates Market, by Payload
    - Auristatins
    - Maytansinoids
    - Calicheamicin Derivatives
    - Others
  - Middle East & Africa Antibody Drug Conjugates Market, by Technology
    - Auristatins (MMAE, MMAF)
    - Maytansinoids (DM1, DM4)
    - Calicheamicin Derivatives
    - Topoisomerase I Inhibitors (SN-38, DXd)
    - Pyrrolobenzodiazepine (PBD) Dimers
    - Others
  - Middle East & Africa Antibody Drug Conjugates Market, by Distribution Channel
    - Hospital Pharmacy
    - Specialty Pharmacy
    - Others
  - South Africa
    - South Africa Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - South Africa Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - South Africa Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - South Africa Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - South Africa Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Saudi Arabia
    - Saudi Arabia Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Saudi Arabia Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Saudi Arabia Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Saudi Arabia Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Saudi Arabia Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - UAE
    - UAE Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - UAE Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - UAE Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - UAE Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - UAE Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others
  - Kuwait
    - Kuwait Antibody Drug Conjugates Market, by Application
      - Breast Cancer
      - Blood Cancer
        
        Lymphoma
        
        Leukemia
      - Urothelial Carcinoma
      - Ovarian Cancer
      - Others
    - Kuwait Antibody Drug Conjugates Market, by Product
      - Kadcyla (ado-trastuzumab emtansine)
      - Enhertu (trastuzumab deruxtecan)
      - Trodelvy (sacituzumab govitecan)
      - Adcetris (brentuximab vedotin)
      - Polivy (polatuzumab vedotin)
      - Others (Padcev, Tivdak, Elahere, Zynlonta, Mylotarg, Besponsa)
    - Kuwait Antibody Drug Conjugates Market, by Payload
      - Auristatins
      - Maytansinoids
      - Calicheamicin Derivatives
      - Others
    - Kuwait Antibody Drug Conjugates Market, by Technology
      - Auristatins (MMAE, MMAF)
      - Maytansinoids (DM1, DM4)
      - Calicheamicin Derivatives
      - Topoisomerase I Inhibitors (SN-38, DXd)
      - Pyrrolobenzodiazepine (PBD) Dimers
      - Others
    - Kuwait Antibody Drug Conjugates Market, by Distribution Channel
      - Hospital Pharmacy
      - Specialty Pharmacy
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments